With only a few weeks to go Oxford Global are proud to bring to you the final agenda for the Advances in Companion Diagnostics and co-located Precision Medicine Congress to be held on the 25-26 April 2017 in London.
Download the agenda here now
Highlights of the co-located programmes include:
- Discover the Latest Regulatory Updates and Challenges to Value Based Medicine with Jen Madsen, Arnold & Porter Kaye Scholer LLP
- Learn about Precision Medicine and Companion Diagnostics Development in Oncology with Carl Barrett, Vice President, Translational Sciences Onc iMed, AstraZeneca
- Leverage on Precision Medicine in Oncology Clinical Studies with Matthew Squires, Global Head Translational Precision Oncology, Novartis Pharmaceuticals
- Discuss the Current Ecosystem for Precision Medicine with Dame Anna Dominiczak, University of Glasgow
- Explore the Latest Imaging and Diagnostic Development in Breast Cancer with Joachim Feldwisch, Director Preclinical Development, Affibody AB
- Learn how Genomics Transform Precision Medicine and Targeted Therapies - The 100,000 Genomes Project and Personalised Medicine with Tim Hubbard, Head of Genome Analysis, Genomics England
- Gain from The Use of NGS in Clinical Diagnostics Testing with Elaine Lyon, Medical Director of Molecular Genetics, ARUP Laboratories
6 interactive streams:
- Companion Diagnostics (CDx) development
- Advances in Molecular Diagnostics
- Imaging and Diagnostic Development
- Companion Diagnostics for NextGeneration Sequencing (NGS) platforms
- Precision Medicine and Diagnostics in discovery and development
- Precision Medicine and Genomics
Free Webinar Recordings Available to download!
1. Challenges in Developing Companion Diagnostics for Cancer and Immunology
2. Pharmacogenomics Biomarkers, Relating to Our Own Discovery/Development
3. Antibody Production, Characterisation and Applications in the Diagnostics Field
Download for free today
4. Clinical Utility of Genomic Testing
Download for free today